Question

multiple choice—circle the correct letter. 25. (lo 1 - 6) which major drug law speeds up drugs’ availability for patients with rare diseases? a. drug regulation and reform act of 1978 b. orphan drug act of 1983 c. pure food and drug act of 1906 d. food, drug, and cosmetic act (fdca) of 1938 26. (lo 1 - 5) what information is covered in a drug reference book? a. type of providers who can prescribe the drug b. interactions with the drug the drug c. which healthcare workers can administer the drug d. color of the drug 27. (lo 1 - 2) what are two uses of drugs? a. produce side effects and adverse reactions b. change the genetic and chemical makeup of the body c. prevent and treat disease d. test the knowledge and skill of the healthcare worker 28. (lo 1 - 3) who requires the use of drug standards? a. hospitals b. patients c. providers d. the law 29. (lo 1 - 4) which drug is listed by a generic name? a. acetylsalicylic acid b. bufferin c. nitro - bid

Explanation:

1. The Orphan Drug Act of 1983 was designed to speed up drugs' availability for rare - disease patients.
2. A drug reference book typically covers information about drug - provider types, drug interactions, and which healthcare workers can administer the drug, but not the color of the drug.
3. The main uses of drugs are to prevent and treat disease. Side - effects are not intended uses, and drugs are not used to change the genetic makeup of the body or test healthcare workers' knowledge.
4. The law requires the use of drug standards to ensure safety and efficacy.
5. Acetylsalicylic acid is a generic name for aspirin, while Bufferin and Nitro - Bid are brand names.

Answer:

1. b. Orphan Drug Act of 1983
2. a. Type of providers who can prescribe the drug, b. Interactions with the drug, c. Which healthcare workers can administer the drug
3. c. Prevent and treat disease
4. d. The law
5. a. Acetylsalicylic acid